CVCT - CardioVascular Clinical Trialists

One global clinical trial. Multiple regulators. Different decisions. At #CVCT2026, experts examine the challenges of international evidence acceptance. Can we harmonize regulatory expectations without compromising scientific rigor? globalcvctforum.com/scientif… #ClinicalTrials #CVCT

A positive clinical trial doesn't automatically change clinical guidelines. At #CVCT2026, trialists,journal editors & regulators debate how evidence becomes clinical recommendations. When is one positive trial enough? globalcvctforum.com/scientif… #ClinicalTrials #EvidenceBasedMedicine

What happens when a clinical trial succeeds, but clinical practice doesn't change? At #CVCT2026, experts explore implementation science, payment reform & the barriers preventing evidence from reaching patients. globalcvctforum.com/scientif… #ClinicalTrials

Clinical trials depend on collaboration. But collaboration depends on trust. At #CVCT2026: data access, scientific independence, transparency & the future of industry-academia partnerships. Join the debate: globalcvctforum.com/scientif… #ClinicalTrials #ResearchIntegrity #CVCT

If CV prevention goes beyond ASCVD, shouldn't trial endpoints do the same? At #CVCT2026, the CVCT–@DCRINews joint session explores heart failure, AF, diabetes & how to measure prevention in at-risk populations. Are we measuring the right outcomes? globalcvctforum.com/scientif…

Can we repair the damaged heart? At #CVCT2026, experts explore cardiac regeneration, targeted biologics & emerging therapies. But should cardiology adopt accelerated pathways to bring regenerative treatments to patients? globalcvctforum.com/scientif… #CVCT #ClinicalTrials

When is a surrogate endpoint enough to demonstrate clinical benefit? At #CVCT2026, experts confront the dilemma shaping the next generation of hypertrophic cardiomyopathy trials: surrogate endpoints vs. hard clinical outcomes. globalcvctforum.com/scientif… #HCM #ClinicalTrials #CVCT

When the treatment landscape changes, clinical trials must evolve too. At #CVCT2026: cardiac amyloidosis, emerging therapies, new trial designs & the challenge of access. How do we turn innovation into meaningful patient care? globalcvctforum.com/scientif… #ATTRCM #ClinicalTrials #CVCT

A trial can show that a treatment works.But does it tell us how patients actually feel? At #CVCT2026, the CVCT–Heart Failure Collaboratory session explores how to make patient-reported outcomes meaningful in clinical trials: globalcvctforum.com/scientif… #HeartFailure #ClinicalResearch

A wearable can generate millions of data points. But when does a signal become clinical evidence? At #CVCT2026, we follow the journey from wrist→ endpoint → regulation → reimbursement → clinical practice. Join the discussion: globalcvctforum.com/scientif… #Wearables #DigitalHealth

#CVCT2026 What if the problem isn’t the therapy - but the trial designed to test it? Are standard RCT designs killing potentially effective hypertension therapies? And can cheap generic treatments coexist with innovative targeted ones? globalcvctforum.com/scientif… #Hypertension

Gene therapy could transform CV medicine. But how do you design a trial for a therapy that may be irreversible? At #CVCT2026: patient selection, durability, safety & how much evidence is enough. Is it time to rethink the trial model? globalcvctforum.com/scientif… #GeneTherapy #CVCT

#CVCT Great Debates Some questions in clinical trials don’t need another lecture. They need a debate. At #CVCT2026, experts take opposing sides on endpoints, multi-organ composites, device vs drug trials & expanded MACE. Join us Dec 7-9, Washington DC: globalcvctforum.com/scientif…

⏳ DEADLINES EXTENDED | #CVCT2026 More time to bring your research to Washington, D.C. 🔬 Late-Breaking Clinical Trials NEW deadline: October 8 📊 Poster Presentations NEW deadline: October 15 Submit: globalcvctforum.com/ #CVCT #LBCT #Posters

LAST CALL | CVCT-LMIC Fellowship Join the global clinical trials community at #CVCT2026 in Washington, DC ✈️ Travel & accommodation covered 🎓 Registration waived 🤝 Mentorship, masterclasses & networking ⏳ Apply by October 8 here: globalcvctforum.com/wac-lmic… #LMIC #ClinicalTrials

⏳ FINAL CALL for Late-Breaking Clinical Trials at #CVCT2026 Bring your latest cardiovascular, kidney & metabolic trial evidence to the global CVCT community in Washington, D.C. 🚨 Deadline: October 1 Submit your LBCT here: globalcvctforum.com/late-bre… #ClinicalTrials #LBCT #CVCT

What if one of the biggest opportunities in CV research is hiding in plain sight? At #CVCT2026, the CVCT-NHLBI joint session explores how implementation problems can become cardiovascular science - and change how care is delivered. Discover full program: globalcvctforum.com/scientif…

Who is really shaping the future of cardiovascular innovation? Academia? Industry? Regulators? CROs? Investors? At #CVCT2026, we'll discuss whether today’s cardiovascular trial model is still sustainable - and what needs to change. Join us, Dec 7-9, 2026: globalcvctforum.com/scientif…

Obesity medicine is evolving fast. Are clinical trials keeping up? At #CVCT2026 we'll discuss: • What do recent CVOTs tell us? • Is weight loss the real mechanism of benefit? • Are we seeing “the death of the pure placebo”? globalcvctforum.com/scientif… #CVCT #Obesity #GLP1

Generative AI & Autonomous Systems. Can we evaluate the unevaluable? At #CVCT2026, experts will discuss whether existing frameworks can truly assess Generative AI in clinical medicine, or whether we need to build new ones. Join us: globalcvctforum.com/scientif… #CVCT #AI